The Turkish translation of the Pulmonary Arterial Hypertension Symptom Scale demonstrates high internal consistency, excellent test-retest reproducibility, and preliminary construct validity in outpatients with pulmonary hypertension, according to a methodological study published in BMC Pulmonary Medicine. Pulmonary hypertension is a progressive disorder characterized by a substantial symptom burden that adversely affects daily functioning and health-related quality of life. Standardized assessment of symptom severity may support clinical follow-up and symptom-focused care.
The Pulmonary Arterial Hypertension Symptom Scale was developed to assess symptom severity in patients with pulmonary arterial hypertension. Prior to this study, a Turkish version of the scale had not undergone formal psychometric evaluation. To address this gap, the researchers sought to evaluate the cross-cultural adaptation, validity, and reliability of the Turkish version among outpatients with pulmonary hypertension.
This methodological study was conducted between March and May 2020 in the pulmonary hypertension outpatient clinic of a university hospital. The study sample comprised 130 adult patients receiving outpatient follow-up care. Participants had a mean age of 60.82 ± 15.40 years. Diagnostic classification indicated that 78.5 percent were classified as pulmonary hypertension group 1 (pulmonary arterial hypertension).
Cross-cultural adaptation involved standard forward and backward translation procedures followed by an expert review to determine content validity. The resulting content validity index was 0.94, confirming acceptable content validity for the translated items. Construct validity was evaluated using exploratory factor analysis and confirmatory factor analysis to compare a one-factor model, the original three-factor model, and an empirical two-factor model. The investigators also examined associations between scale scores and established clinical indicators to evaluate construct validity.
Exploratory factor analysis suggested a two-factor structure, categorized into cardiac and pulmonary dimensions, which explained 60.7 percent of the total variance. In confirmatory factor analysis, the original three-factor model demonstrated poor fit and near-unity factor correlations between 0.97 and 0.99. When six error covariances were incorporated, the two-factor model achieved borderline-to-acceptable fit, yielding a chi-square to degrees of freedom ratio of 2.00, a comparative fit index of 0.93, a Tucker-Lewis index of 0.91, a root mean square error of approximation of 0.09, and a standardized root mean square residual of 0.05. Although the two-factor model fitted better than a one-factor model, the cardiac and pulmonary factors remained very highly correlated at r = 0.93.
Internal consistency analysis revealed a Cronbach’s alpha of 0.943 for the total scale, 0.925 for the cardiac subscale, and 0.868 for the pulmonary subscale, supported by McDonald’s omega and item-total correlations. Test-retest reliability was assessed in a subsample of 30 patients using intraclass correlation coefficients. This analysis yielded an intraclass correlation coefficient of 0.991 with a 95 percent confidence interval from 0.979 to 0.996, indicating excellent score reproducibility over time.
Total scores correlated with 6-minute walk distance (ρ = −0.37), oxygen saturation (ρ = −0.27), and functional class (ρ = 0.23). Total scores were higher in patients reporting symptom exacerbation.
Because the cardiac and pulmonary factors were very highly correlated and both exploratory and confirmatory factor analyses were conducted in the same sample, the researchers recommended utilizing the total score as the primary clinical metric. The scale may be useful for symptom assessment in pulmonary hypertension outpatient follow-up, but further validation in larger, independent, and pulmonary arterial hypertension-specific samples is needed.
Subject of Research: Psychometric evaluation of the Turkish Pulmonary Arterial Hypertension Symptom Scale
Article Title: Cross-cultural adaptation and psychometric evaluation of the Turkish version of the Pulmonary Arterial Hypertension Symptom Scale in patients with pulmonary hypertension
Article References: Yılmaz Keşlikli, C., & Sezgi̇n, D. (2026). Cross-cultural adaptation and psychometric evaluation of the Turkish version of the Pulmonary Arterial Hypertension Symptom Scale in patients with pulmonary hypertension. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-026-05005-4
Image Credits: AI Generated
DOI: 10.1186/s12890-026-05005-4
Keywords: Pulmonary hypertension, Pulmonary arterial hypertension, PAHSS, Psychometric evaluation, Cross-cultural adaptation, Content validity index, Exploratory factor analysis, Confirmatory factor analysis, Internal consistency, Cronbach's alpha, Test-retest reliability, Intraclass correlation coefficient, Six-minute walk distance, Oxygen saturation, Outpatient care, Symptom severity assessment
News Source: Ophelia Keating. (November 20, 2026). Turkish Pulmonary Arterial Hypertension Symptom Scale Shows Preliminary Construct Validity. Scienmag.



